BioMed Pharmacother
Nausea, vomiting, diarrhea, constipation, bloating, reflux, and reduced appetite may occur, especially during dose changes
Semaglutide is typically prescribed for adults with obesity or overweight (BMI 27 kg/m) who also have a weight-related comorbidity, such as type 2 diabetes, high blood pressure, or sleep apnea
PMID: 52 ReidCTTobinAMAhernTOSheaDKirbyB
These medications can cause serious but rare side effects including gallbladder problems and pancreatitis which require immediate attention
Choose brand-name (Mounjaro or Zepbound) if: Your insurance covers it with a manageable copay (often $25 with Eli Lilly savings card) You qualify for the FDA-approved indication (BMI threshold, T2D diagnosis) You prefer FDA-registered manufacturing standardization You want the clinical trial evidence directly applicable to what you are taking Consider compounded tirzepatide if: You are paying cash and the brand is unaffordable You do not meet FDA-approved BMI thresholds but want medical supervision for GLP-1/GIP therapy You need a customized formulation Your physician has worked with reputable compounding pharmacies and can verify quality How to Access Each Brand: Doctor visit prescription pharmacy fill insurance prior authorization or cash pay